| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000029711 |
| Receipt No. | R000032312 |
| Scientific Title | The efficacy of the tailored sleep hygiene intervention on the sleep disturbance, absenteeism, and presenteeism among adolescent: A randomized controlled study. |
| Date of disclosure of the study information | 2017/10/25 |
| Last modified on | 2019/04/25 (Ver. 5) |
| Basic information | ||
| Public title | The efficacy of the tailored sleep hygiene intervention on the sleep disturbance, absenteeism, and presenteeism among adolescent: A randomized controlled study. | |
| Acronym | The efficacy of the tailored sleep hygiene intervention on the sleep disturbance, absenteeism, and presenteeism among adolescent: A randomized controlled study. | |
| Scientific Title | The efficacy of the tailored sleep hygiene intervention on the sleep disturbance, absenteeism, and presenteeism among adolescent: A randomized controlled study. | |
| Scientific Title:Acronym | The efficacy of the tailored sleep hygiene intervention on the sleep disturbance, absenteeism, and presenteeism among adolescent: A randomized controlled study. | |
| Region |
|
|
| Condition | |||||
| Condition | Sleep disturbance and sleep problems | ||||
| Classification by specialty |
|
||||
| Classification by malignancy | Others | ||||
| Genomic information | NO | ||||
| Objectives | |
| Narrative objectives1 | To assess the efficacy of tailored sleep hygiene intervention in adolescent with absenteeism or presenteeism suffering from a sleep disturbance. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Absenteeism from the intervention to the end of the school year. |
| Key secondary outcomes | 1) Sleep measurements (PSQI, PDSS, SJL, etc.)
2) Absenteeism after the next school year of the intervention 3) The rate of school promotion, holdover, and leaving 4) Presenteeism 5) School achievement 6) Daytime sleepiness and snooze 7) The difference of the intervention efficacy between by a specialist and by a non-specialist |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Placebo |
| Stratification | YES |
| Dynamic allocation | NO |
| Institution consideration | Institution is considered as a block. |
| Blocking | YES |
| Concealment | Central registration |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Educational,Counseling,Training | |
| Type of intervention |
|
|
| Interventions/Control_1 | Intervention group | |
| Interventions/Control_2 | Sham control group | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | To satisfy ALL the criteria shown below:
(1) Belonging to any kind of school, or being equal or over 12 years old (except elementary school students) and under 25 years old when registered to the study (2) Being suffered from sleep disturbance or sleep problem (ex. PSQI>5.5, SJL>2h, subjective insomnia) (3) Having absenteeism or presenteeism |
|||
| Key exclusion criteria | To satisfy ANY of the criteria shown below:
(1) Those who disagreed with the study. (2) Those whose parents disagreed with the study if the participant is equal or under 19 years old. (3) whose age is equal or over 25 years old. (4) Those who had taken a sleep clinic on sleep disorder before the intervention. (5) Those whose absenteeism had greatly affected by severe diseases, injury, and/or death of themselves or their relatives during the period of the study. |
|||
| Target sample size | 200 | |||
| Research contact person | |||||||
| Last name of lead principal investigator |
|
||||||
| Organization | Tokyo medical university | ||||||
| Division name | Psychiatry | ||||||
| Zip code | 160-0023 | ||||||
| Address | 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo, Japan | ||||||
| TEL | 03-3342-6111 | ||||||
| sim@tokyo-med.ac.jp | |||||||
| Public contact | |||||||
| 1st name of contact person |
|
||||||
| Organization | Tokyo medical university | ||||||
| Division name | Psychiatry | ||||||
| Zip code | 160-0023 | ||||||
| Address | 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo, Japan | ||||||
| TEL | 03-3342-6111 | ||||||
| Homepage URL | |||||||
| sim@tokyo-med.ac.jp | |||||||
| Sponsor | |
| Institute | Tokyo medical university |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Ministry of Education, Culture, Sports, Science and Technology / Japan Society for the Promotion of Science |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Tokyo Medical University Institutional Review Board |
| Address | 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo, Japan |
| Tel | 03-3342-6111 |
| IRB@tokyo-med.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032312 |